+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study



Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study



Journal of Neuropsychiatry and Clinical Neurosciences 9(1): 29-36



The efficacy of sustained-release methylphenidate (MSR) was examined in a sample of substance abusers with HIV-1-related cognitive impairment. Eight HIV-1-infected methadone patients with impaired neuropsychological test performance participated in an inpatient double-blind placebo-controlled crossover trial of MSR (20 to 40 mg/day). On a composite neuropsychological measure, patients improved significantly from baseline during MSR but not placebo treatment.

(PDF emailed within 0-6 h: $19.90)

Accession: 002973864

Download citation: RISBibTeXText

PMID: 9017526

DOI: 10.1176/jnp.9.1.29


Related references

Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug and Alcohol Dependence 108(1-2): 130-133, 2010

Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment. Journal of Psychoactive Drugs 35(2): 209-218, 2003

Relative efficacy of long acting stimulants on children with attention deficit hyperactivity disorder a comparison of standard methylphenidate sustained release methylphenidate sustained release dextro amphetamine and pemoline. Pediatrics 86(2): 226-237, 1990

Usefulness of sweat testing for the detection of methylphenidate after fast- and extended-release drug administration: a pilot study. Therapeutic Drug Monitoring 32(4): 508-511, 2010

Peptide t treatment of cognitive impairment in hiv positive intravenous drug abusers. Society for Neuroscience Abstracts 17(1-2): 1595, 1991

Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. Journal of Clinical Psychiatry 59(6): 300-305, 1998

Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder. Pediatrics 80(4): 491-501, 1987

Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy-tolerability pilot study. Neuropsychiatric Disease and Treatment 12(): 559-569, 2016

Sustained effectiveness of osmotic-release methylphenidate: a study of 266 cases. Revista de Neurologia 48(7): 339-345, 2009

Biological markers in the study of HIV infected and HIV non-infected drug abusers. TENTH INTERNATIONAL CONFERENCE ON AIDS, INTERNATIONAL CONFERENCE ON STD [Author] Tenth International Conference on AIDS and the International Conference on STD, Vol 1; The global challenge of AIDS: Together for the future : 1) 159, 1994

Cognitive training changes hippocampal function in mild cognitive impairment: a pilot study. Journal of Alzheimer's Disease 26 Suppl 3: 349-357, 2012

Tai Ji Quan and global cognitive function in older adults with cognitive impairment: a pilot study. Archives of Gerontology and Geriatrics 58(3): 434-439, 2014

A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA). Schizophrenia Research 158(1-3): 151-155, 2015

Enhancing latent cognitive capacity in mild cognitive impairment with gist reasoning training: a pilot study. International Journal of Geriatric Psychiatry (): -, 2016